{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:32:32Z","timestamp":1793403152807,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of cutaneous melanoma (CM) has been increasing annually worldwide. In this study, we identify that MrgprF, a MAS related GPR family member, is decreased in cutaneous melanoma tissues and cell lines due to hypermethylation of its promoter region, and show that patients with CM expressing high levels of MrgprF exhibit an improved clinical outcome. We demonstrate that MrgprF forced expression inhibits tumor cell proliferation, migration, xenograft tumor growth, and metastasis. On the contrary, MrgprF knockdown promotes tumor cell proliferation and transformation of immortalized human keratinocyte-HaCaT cells, supporting the inhibitory role of MrgprF during tumor progression. Mechanistic studies reveal that MrgprF reduces the phosphoinositol\u20113\u2011kinase (PI3K) complex formation between p101 and p110\u03b3 subunits, the critical step for phosphatidylinositol-(3, 4)-P2 (PIP2) conversion to phosphatidylinositol-(3, 4, 5)-P3 (PIP3), and then reduces the activation of PI3K\/Akt signaling. This effect can be reversed by Akt specific agonist SC79. In addition, AMG 706, a previously documented inhibitor for endothelial cell proliferation, is identified as a potential agonist for MrgprF, and can impede tumor growth both in vitro and in vivo. Taken together, our findings suggest that MrgprF, a novel tumor suppressor in cutaneous melanoma, may be useful as a therapeutic target in the future.<\/jats:p>","DOI":"10.1038\/s41392-022-00945-9","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:02:42Z","timestamp":1651622562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K\/Akt signaling"],"prefix":"10.1038","volume":"7","author":[{"given":"Qiushuo","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaomei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-6991","authenticated-orcid":false,"given":"Yongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"945_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","volume":"33","author":"RI Hartman","year":"2019","unstructured":"Hartman, R. I. & Lin, J. Y. Cutaneous melanoma-a review in detection, staging, and management. Hematol. Oncol. Clin. North Am. 33, 25\u201338 (2019).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"945_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ad.2018.11.009","volume":"110","author":"N Iglesias-Pena","year":"2019","unstructured":"Iglesias-Pena, N., Paradela, S., Tejera-Vaquerizo, A., Boada, A. & Fonseca, E. Cutaneous melanoma in the elderly: review of a growing problem. Actas Dermosifiliogr. 110, 434\u2013447 (2019).","journal-title":"Actas Dermosifiliogr."},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"e4757","DOI":"10.1136\/bmj.e4757","volume":"345","author":"M Boniol","year":"2012","unstructured":"Boniol, M., Autier, P., Boyle, P. & Gandini, S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 345, e4757 (2012).","journal-title":"BMJ"},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djp038","volume":"101","author":"BE Gould Rothberg","year":"2009","unstructured":"Gould Rothberg, B. E., Bracken, M. B. & Rimm, D. L. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl Cancer Inst. 101, 452\u2013474 (2009).","journal-title":"J. Natl Cancer Inst."},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","volume":"36","author":"O Abbas","year":"2014","unstructured":"Abbas, O., Miller, D. D. & Bhawan, J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am. J. Dermatopathol. 36, 363\u2013379 (2014).","journal-title":"Am. J. Dermatopathol."},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3892\/or.2014.3103","volume":"31","author":"KR Lee","year":"2014","unstructured":"Lee, K. R., Lee, J. S., Kim, Y. R., Song, I. G. & Hong, E. K. Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-kappaB signaling pathway. Oncol. Rep. 31, 2447\u20132453 (2014).","journal-title":"Oncol. Rep."},{"key":"945_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejcb.2014.01.002","volume":"93","author":"N Moro","year":"2014","unstructured":"Moro, N., Mauch, C. & Zigrino, P. Metalloproteinases in melanoma. Eur. J. Cell Biol. 93, 23\u201329 (2014).","journal-title":"Eur. J. Cell Biol."},{"key":"945_CR8","first-page":"1071","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi, G. C. et al. Cutaneous melanoma: From pathogenesis to therapy (Review). Int J. Oncol. 52, 1071\u20131080 (2018).","journal-title":"Int J. Oncol."},{"key":"945_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.18632\/oncotarget.240","volume":"2","author":"WH Chappell","year":"2011","unstructured":"Chappell, W. H. et al. Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2, 135\u2013164 (2011).","journal-title":"Oncotarget"},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.critrevonc.2015.08.021","volume":"96","author":"MS Carlino","year":"2015","unstructured":"Carlino, M. S., Long, G. V., Kefford, R. F. & Rizos, H. Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma. Crit. Rev. Oncol. Hematol. 96, 385\u2013398 (2015).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"945_CR11","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","volume":"26","author":"M Raman","year":"2007","unstructured":"Raman, M., Chen, W. & Cobb, M. H. Differential regulation and properties of MAPKs. Oncogene 26, 3100\u20133112 (2007).","journal-title":"Oncogene"},{"key":"945_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/PPO.0b013e31824d448c","volume":"18","author":"MA Davies","year":"2012","unstructured":"Davies, M. A. The role of the PI3K-AKT pathway in melanoma. Cancer J. 18, 142\u2013147 (2012).","journal-title":"Cancer J."},{"key":"945_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke, J. J., Flaherty, K. T., Ribas, A. & Long, G. V. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat. Rev. Clin. Oncol. 14, 463\u2013482 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"945_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jso.21962","volume":"104","author":"MI Ross","year":"2011","unstructured":"Ross, M. I. & Gershenwald, J. E. Evidence-based treatment of early-stage melanoma. J. Surg. Oncol. 104, 341\u2013353 (2011).","journal-title":"J. Surg. Oncol."},{"key":"945_CR15","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.7150\/thno.19425","volume":"7","author":"QG Li","year":"2017","unstructured":"Li, Q. G. et al. A normalization-free and nonparametric method sharpens large-scale transcriptome analysis and reveals common gene alteration patterns in cancers. Theranostics 7, 2888\u20132899 (2017).","journal-title":"Theranostics"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(01)00483-4","volume":"106","author":"X Dong","year":"2001","unstructured":"Dong, X., Han, S., Zylka, M. J., Simon, M. I. & Anderson, D. J. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106, 619\u2013632 (2001).","journal-title":"Cell"},{"key":"945_CR17","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1101\/gr.1431603","volume":"13","author":"SS Choi","year":"2003","unstructured":"Choi, S. S. & Lahn, B. T. Adaptive evolution of MRG, a neuron-specific gene family implicated in nociception. Genome Res 13, 2252\u20132259 (2003).","journal-title":"Genome Res"},{"key":"945_CR18","doi-asserted-by":"publisher","first-page":"e38618","DOI":"10.1371\/journal.pone.0038618","volume":"7","author":"S Nishimura","year":"2012","unstructured":"Nishimura, S. et al. MRGD, a MAS-related G-protein coupled receptor, promotes tumorigenisis and is highly expressed in lung cancer. PLoS One 7, e38618 (2012).","journal-title":"PLoS One"},{"key":"945_CR19","first-page":"1101","volume":"20","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Expression and clinical contribution of MRGD mRNA in non-small cell lung cancers. J. BUON 20, 1101\u20131106 (2015).","journal-title":"J. BUON"},{"key":"945_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00441-019-03017-7","volume":"377","author":"C Zhou","year":"2019","unstructured":"Zhou, C. et al. Expression and localization of MrgprD in mouse intestinal tract. Cell Tissue Res 377, 259\u2013268 (2019).","journal-title":"Cell Tissue Res"},{"key":"945_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.proghi.2015.06.001","volume":"50","author":"H Wu","year":"2015","unstructured":"Wu, H., Zeng, M., Cho, E. Y., Jiang, W. & Sha, O. The origin, expression, function and future research focus of a G protein-coupled receptor, mas-related gene X2 (MrgX2). Prog. Histochem Cytochem 50, 11\u201317 (2015).","journal-title":"Prog. Histochem Cytochem"},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.7150\/thno.39740","volume":"10","author":"J Song","year":"2020","unstructured":"Song, J. et al. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFbeta signaling in colorectal cancer. Theranostics 10, 2327\u20132341 (2020).","journal-title":"Theranostics"},{"key":"945_CR23","doi-asserted-by":"publisher","first-page":"E1334","DOI":"10.1210\/jc.2013-1053","volume":"98","author":"H Guan","year":"2013","unstructured":"Guan, H. et al. Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer. J. Clin. Endocrinol. Metab. 98, E1334\u2013E1344 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"945_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/or.2014.3581","volume":"33","author":"PH Lo","year":"2015","unstructured":"Lo, P. H., Tanikawa, C., Katagiri, T., Nakamura, Y. & Matsuda, K. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma. Oncol. Rep. 33, 267\u2013273 (2015).","journal-title":"Oncol. Rep."},{"key":"945_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/pcmr.12168","volume":"27","author":"TJ Park","year":"2014","unstructured":"Park, T. J. et al. Wnt inhibitory factor (WIF)-1 promotes melanogenesis in normal human melanocytes. Pigment Cell Melanoma Res 27, 72\u201381 (2014).","journal-title":"Pigment Cell Melanoma Res"},{"key":"945_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2535-8","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K\/Akt pathway. Cell Death Dis. 11, 320 (2020).","journal-title":"Cell Death Dis."},{"key":"945_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res"},{"key":"945_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"945_CR29","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"945_CR30","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu, C. J. et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics 34, 3771\u20133772 (2018).","journal-title":"Bioinformatics"},{"key":"945_CR31","doi-asserted-by":"publisher","first-page":"D856","DOI":"10.1093\/nar\/gkz830","volume":"48","author":"W Ding","year":"2020","unstructured":"Ding, W. et al. DNMIVD: DNA methylation interactive visualization database. Nucleic Acids Res 48, D856\u2013D862 (2020).","journal-title":"Nucleic Acids Res"},{"key":"945_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur, V. et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10, 277\u2013288 (2018).","journal-title":"Epigenomics"},{"key":"945_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2005.01.012","volume":"230","author":"Z Liu","year":"2005","unstructured":"Liu, Z. et al. 5-Aza-2\u2019-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett. 230, 271\u2013283 (2005).","journal-title":"Cancer Lett."},{"key":"945_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko, F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat. Rev. Genet 19, 81\u201392 (2018).","journal-title":"Nat. Rev. Genet"},{"key":"945_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"945_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2019.12.003","volume":"37","author":"JL Orgaz","year":"2020","unstructured":"Orgaz, J. L. et al. Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance. Cancer Cell 37, 85\u2013103 e109 (2020).","journal-title":"Cancer Cell"},{"key":"945_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrd2926","volume":"8","author":"P Liu","year":"2009","unstructured":"Liu, P., Cheng, H., Roberts, T. M. & Zhao, J. J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627\u2013644 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"945_CR38","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.1073\/pnas.1202810109","volume":"109","author":"H Jo","year":"2012","unstructured":"Jo, H. et al. Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc. Natl Acad. Sci. 109, 10581\u201310586 (2012).","journal-title":"Proc. Natl Acad. Sci."},{"key":"945_CR39","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.1158\/0008-5472.CAN-05-4665","volume":"66","author":"A Polverino","year":"2006","unstructured":"Polverino, A. et al. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Cancer Res 66, 8715\u20138721 (2006).","journal-title":"Cancer Res"},{"key":"945_CR40","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41422-021-00517-6","volume":"31","author":"D Xu","year":"2021","unstructured":"Xu, D. et al. A single mutation underlying phenotypic convergence for hypoxia adaptation on the Qinghai-Tibetan Plateau. Cell Res 31, 1032\u20131035 (2021).","journal-title":"Cell Res"},{"key":"945_CR41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/nsr\/nwz213","volume":"7","author":"DD Wu","year":"2020","unstructured":"Wu, D. D. et al. Convergent genomic signatures of high-altitude adaptation among domestic mammals. Natl Sci. Rev. 7, 952\u2013963 (2020).","journal-title":"Natl Sci. Rev."},{"key":"945_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12801-6","volume":"10","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. Nat. Commun. 10, 4892 (2019).","journal-title":"Nat. Commun."},{"key":"945_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4682-11-S1-S8","volume":"11","author":"M El Baroudi","year":"2014","unstructured":"El Baroudi, M., La Sala, D., Cinti, C. & Capobianco, E. Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines. Theor. Biol. Med Model 11, S8 (2014).","journal-title":"Theor. Biol. Med Model"},{"key":"945_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3892\/ijmm.2016.2704","volume":"38","author":"W Li","year":"2016","unstructured":"Li, W. et al. 5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1. Int J. Mol. Med 38, 1047\u20131054 (2016).","journal-title":"Int J. Mol. Med"},{"key":"945_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/bjc.1987.187","volume":"56","author":"R Cortvrindt","year":"1987","unstructured":"Cortvrindt, R., Bernheim, J., Buyssens, N. & Roobol, K. 5-Azacytidine and 5-aza-2\u2019-deoxycytidine behave as different antineoplastic agents in B16 melanoma. Br. J. Cancer 56, 261\u2013265 (1987).","journal-title":"Br. J. Cancer"},{"key":"945_CR46","first-page":"6124","volume":"45","author":"DL Trainer","year":"1985","unstructured":"Trainer, D. L., Kline, T., Mallon, F., Greig, R. & Poste, G. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells. Cancer Res 45, 6124\u20136130 (1985).","journal-title":"Cancer Res"},{"key":"945_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jpha.2020.01.001","volume":"10","author":"S Usman","year":"2020","unstructured":"Usman, S., Khawer, M., Rafique, S., Naz, Z. & Saleem, K. The current status of anti-GPCR drugs against different cancers. J. Pharm. Anal. 10, 517\u2013521 (2020).","journal-title":"J. Pharm. Anal."},{"key":"945_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fgene.2016.00112","volume":"7","author":"RA Rosero","year":"2016","unstructured":"Rosero, R. A., Villares, G. J. & Bar-Eli, M. Protease-activated receptors and other G-protein-coupled receptors: the melanoma connection. Front Genet 7, 112 (2016).","journal-title":"Front Genet"},{"key":"945_CR49","doi-asserted-by":"publisher","first-page":"17152","DOI":"10.1074\/jbc.274.24.17152","volume":"274","author":"S Krugmann","year":"1999","unstructured":"Krugmann, S., Hawkins, P. T., Pryer, N. & Braselmann, S. Characterizing the interactions between the two subunits of the p101\/p110gamma phosphoinositide 3-kinase and their role in the activation of this enzyme by G beta gamma subunits. J. Biol. Chem. 274, 17152\u201317158 (1999).","journal-title":"J. Biol. Chem."},{"key":"945_CR50","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang, F. et al. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17, 590\u2013603 (2003).","journal-title":"Leukemia"},{"key":"945_CR51","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1038\/onc.2008.244","volume":"27","author":"L Zhao","year":"2008","unstructured":"Zhao, L. & Vogt, P. K. Class I PI3K in oncogenic cellular transformation. Oncogene 27, 5486\u20135496 (2008).","journal-title":"Oncogene"},{"key":"945_CR52","doi-asserted-by":"publisher","first-page":"e91419","DOI":"10.1172\/jci.insight.91419","volume":"2","author":"X Zuo","year":"2017","unstructured":"Zuo, X. et al. Metastasis regulation by PPARD expression in cancer cells. JCI Insight 2, e91419 (2017).","journal-title":"JCI Insight"},{"key":"945_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.88","volume":"8","author":"L Yin","year":"2017","unstructured":"Yin, L. et al. NCAPH plays important roles in human colon cancer. Cell Death Dis. 8, e2680 (2017).","journal-title":"Cell Death Dis."},{"key":"945_CR54","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41, D991\u2013D995 (2013).","journal-title":"Nucleic Acids Res"},{"key":"945_CR55","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium, G. T. The genotype-tissue expression (GTEx) project. Nat. Genet 45, 580\u2013585 (2013).","journal-title":"Nat. Genet"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00945-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:14:52Z","timestamp":1669230892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-00945-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the Life Science Ethics Committee of Zhengzhou University, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"147"}}